Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J-P. Zellweger (Fribourg, Switzerland). MDR-TB: from epidemiology to treatment design. Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management

Member's Comments

- 21.10.2011 18:43
None of the power point presentations are downloadable. They cannot be opened and cannot be saved in the current format of .pptx. Please check..

Related content which might interest you: Treatment of migrants with tuberculosis in an era of emerging drug resistance Source: Annual Congress 2010 - Tuberculosis drug resistance and migration Year: 2010 Overview of treatment modalities Source: Annual Congress 2011 - PG15 Treatment of obstructive sleep apnoea Year: 2011 Overview of treatment modalities Source: Annual Congress 2010 - PG19 Postgraduate Course: Treatment of obstructive sleep apnoea Year: 2010 Bedaquiline-containing regimens for MDR TB treatment – Focus on the safety Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 XDR-TB and MDR-TB in Europe: still a challenge Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management Year: 2011 Extensively drug-resistant tuberculosis (XDR-TB) treatment outcome. Cohort study Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis Year: 2010 Development of a standardized tool to survey MDR-/XDR-TB case management in Europe Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis Year: 2010 First second line anti-tuberculosis drug resistance survey in Romania Source: Annual Congress 2011 - Multidrug-resistant tuberculosis Year: 2011 Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 Treatment outcomes for multidrug-resistant tuberculosis (MDR-TB) patients in Africa Source: Annual Congress 2011 - Multidrug-resistant tuberculosis Year: 2011 Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 New approaches for diagnosis and management of COPD Source: Annual Congress 2010 - GOLD Update Year: 2010 Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010 Effectiveness and safety of six month chemotherapy course of XDR TB including bedaquiline and linezolid Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 How soon does tuberculosis in HIV infected patients respond to anti-tuberculous treatment? Source: Annual Congress 2010 - Tuberculosis and HIV coinfection Year: 2010 Successful treatment of multidrug-resistant tuberculosis through a binational consortium Source: Annual Congress 2011 - Multidrug-resistant tuberculosis Year: 2011 Medico-surgical considerations when looking for treatment for multidrug-resistant TB Source: Eur Respir J 2002; 20: Suppl. 38, 361s Year: 2002 XDR-TB in South Africa: from clinical management to public-health action Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management Year: 2011 Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Antibiotic choice in hospitals; a European perspective Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice Year: 2010